SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-013150
Filing Date
2021-03-15
Accepted
2021-03-15 16:05:33
Documents
4
Period of Report
2021-03-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K achv-8k_20210309.htm 8-K 35136
2 EX-99.1 achv-ex991_6.htm EX-99.1 13140
3 GRAPHIC gwsm3oomx4zv000001.jpg GRAPHIC 12043
4 GRAPHIC gwsm3oomx4zv000002.jpg GRAPHIC 13580
  Complete submission text file 0001564590-21-013150.txt   85339
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 21741516
SIC: 2835 In Vitro & In Vivo Diagnostic Substances